Physician Assistant in Butler, PA Accepting Medicare
85 Physician Assistant nurses found. Showing 81 - 85
 Isabella Zonna, PA-C Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 1 Hospital Way, Butler, PA 16001 Phone: 724-482-4099 |
Katherine Elaine O'leary, PA-C Physician Assistant - Surgical Medicare: Accepting Medicare Assignments Practice Location: 129 Oneida Valley Rd Ste 111, Butler, PA 16001 Phone: 724-431-4190 |
 Mr. Gary Trevor Young, P.A.-C Physician Assistant - Surgical Medicare: Accepting Medicare Assignments Practice Location: 127 Oneida Valley Rd Ste 202, Butler, PA 16001 Phone: 724-282-4370 Fax: 724-431-2288 |
Alanna Cellini, Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 901 E Brady St, Suite 300a, Butler, PA 16001 Phone: 724-285-9200 |
Mrs. Alexus Nahil Nubani, PA-C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Way, Butler, PA 16001 Phone: 330-240-8197 |
News Archive
Interleukin-2 shows promise against advanced melanoma
A vaccine for one of the most lethal cancers, advanced melanoma, has shown improved response rates and progression-free survival for patients when combined with the immunotherapy drug, Interleukin-2, according to researchers from The University of Texas M. D. Anderson Cancer Center.
Discovery Labs submits IND application to start AEROSURF phase 2 clinical program
Discovery Laboratories, Inc., a specialty biotechnology company dedicated to advancing a new standard of respiratory critical care, today announced that it has submitted an investigational new drug application to the U.S. Food and Drug Administration to initiate its AEROSURF phase 2 clinical program.
Short and long sleepers more likely to have metabolic syndrome
A study published in the May 1 issue of the journal SLEEP is the first known to report that short and long sleepers are more likely to have metabolic syndrome, or a combination of medical disorders that increase the risk of developing cardiovascular disease.
Pfizer terminates clinical studies evaluating domagrozumab for treatment of Duchenne muscular dystrophy
Pfizer Inc. announced today that it is terminating two ongoing clinical studies evaluating domagrozumab (PF-06252616) for the treatment of Duchenne muscular dystrophy (DMD): a Phase 2 safety and efficacy study (B5161002) and an open-label extension study (B5161004).
Recovery-focused CBT aids bipolar patients
Cognitive behavioural therapy that is focused broadly on patients' recovery may be an effective intervention for patients with recent-onset bipolar disorder, a pilot randomised trial indicates.
› Verified 6 days ago
Nurse Practitioner
Physician Assistant
Registered Nurse
Nurse Anesthetist - CR